StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — J.P. Morgan

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byJ.P. MorganHorizon: NA (inferred 1 year)31 Jul 2026via Zee Business (Live)

Entry₹4,948Inferred
Target₹5,950
Total upside +20.25%
Stop lossNot given
CMP₹4,615.3Just now
Active-6.72%+28.92%upside left 9 mo left
Follow J.P. Morgan for new calls(100% target hit, 18 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on TORNTPHARMSee 212 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 4:05 pm IST
16 supporting6 neutral7 opposing
Supports the BUY call (16)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·21 Oct · yesterday

India Ratings and Research has affirmed the company's credit rating at IND AA+ and revised the outlook from stable to positive for its banking facilities, issuer rating, and non-convertible debentures

BSE · Company Update·7 Oct · 2w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Oct · 2w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·29 Sept · 3w ago

Torrent Pharmaceuticals stock reports 54.6 percent sales growth

NewsGoogle News·25 Sept · 4w ago

(opens in new tab)
Neutral / worth noting (6)

Q2 FY27 results scheduled — board meets 23 Oct 2026

BSE · Board Meeting·In 1 day

(opens in new tab)
Weighs against the BUY call (7)

Torrent accepts Kelshikar resignation: October 23 call for Torrent Pharmaceuticals stock

NewsGoogle News·19 Oct · 3d ago

(opens in new tab)

Torrent Pharmaceuticals accepts resignation of Executive Director Amal Kelshikar

NewsGoogle News·16 Oct · 5d ago

(opens in new tab)

Torrent Pharmaceuticals (NSE:TORNTPHARM): Who Has Resigned as Executive Director?

NewsGoogle News·16 Oct · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from J.P. Morgan

Every call and its outcome